IMPROVAC BOAR TAINT VACCINE FOR MALE PIGS

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

GNRF - PROTEIN CONJUGATE; THIOMERSAL

Available from:

ZOETIS AUSTRALIA PTY LTD

INN (International Name):

GnRF-protein conjugate(200ug/mL)

Pharmaceutical form:

MISC. VACCINES OR ANTI SERA

Composition:

GNRF - PROTEIN CONJUGATE BIOLOGICAL-PROTEIN Active 200.0 ug/ml; THIOMERSAL MERCURY Other 0.1 mg/ml

Units in package:

100mL; 500mL

Class:

VM - Veterinary Medicine

Manufactured by:

ZOETIS AUSTRALIA

Therapeutic group:

PIGS | BOAR | GILT | PIGLET | SOW | SWINE

Therapeutic area:

IMMUNOTHERAPY

Therapeutic indications:

BOAR TAINT

Product summary:

Poison schedule: 4; Withholding period: WHP: NIL; Host/pest details: PIGS: [BOAR TAINT]; Poison schedule: 4; Withholding period: ; Host/pest details: PIGS: [BOAR TAINT]; For the production of heavier entire male pigs with improved meat quality through the control of boar taint; for behavioural modification which may be evidenced by increased weight gain in peripubertal male pigs during the post-vaccination preslaughter..Contraindicated for use in male pig breeding stock. Inadvertent vaccination of male pig breeding stock may affect subsequent fertility.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

AUSTRALIAN GOVERNMENT
RLP
APPENDIX 2
Approved
TEMPLATE FOR RELEVANT LABEL PARTICULARS (RLPS)
(VETERINARY PRODUCTS)
Select appropriate:
0 New Product (include all applicable RLPs) OR
RI Variation (highlight instructions that are being varied). Approval
no. of label being varied: 50113/0510
Signal heading:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Product name:
Improvac® Boar Taint Vaccine for Male Pigs
Active constituent/s:
lmprovac Boar Taint Vaccine for Male Pigs is prepared from an analogue
of GnRF
linked to a carrier protein. It is adjuvanted with a synthetic aqueous
adjuvant to
increase the level and duration of immunity. Each mL of vaccine
provides 200 ,ug
GnRF-protein conjugate. Thiomersal 0.1 mg/mL has been added as a
preservative.
Statement of claims:
For the production of heavier entire male pigs with improved meat
quality through the
control of boar taint; for behavioural modification which may be
evidenced
by
increased weight gain in peripubertal male pigs during the
post-vaccination
preslaughter period. This increased weight gain may also result in
increased fat
deposition.
Net contents:
100 [500] mL
Directions for Use
Heading:
READ THE ENCLOSED LEAFLET BEFORE USING THIS
PRODUCT
DIRECTIONS FOR USE
This product can be stored and used for up to 30 days after first
opening.
On each
subsequent reuse,
swab the opening with a suitable disinfectant (for example,
methylated spirits) both before and after using. A sterile needle and
syringe must be
used each time product is removed.
Contents should be left in outer package until immediately before use.
Restraints:
NA
Contraindications:
This product is contraindicated for use in male pig breeding stock.
Inadvertent vaccination of male pig breeding stock may affect
subsequent fertility.
Precautions:
NA
Side effects:
Some swelling may develop at the site of vaccination, and in a small
proportion of
pigs, may last for several weeks before gradually subsiding.
Dosage &
administration:
Dosage and Administration:
The dose on

Summary of Product characteristics

PRODUCT NAME: IMPROVAC
®
PAGE: 1 OF 5
THIS REVISION ISSUED: NOVEMBER, 2012
MATERIAL SAFETY DATA SHEET
Issued by: Pfizer Australia Pty Ltd
Phone: [phone]
SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
Pfizer Australia Pty Ltd
38-42 Wharf Road
West Ryde NSW 2114
Tel: [phone]
Fax: [phone]
____________________________________
PFIZER AUSTRALIA PTY LTD
A.B.N. 50 008 422 348
SUBSTANCE:
Water solution of ingredients.
TRADE NAME:
IMPROVAC
®
PRODUCT USE:
For the suppression of boar taint in the meat of male pigs.
CREATION DATE:
OCTOBER, 2004
THIS VERSION ISSUED:
NOVEMBER, 2012
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Hazardous according to the criteria of SWA Australia.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
R61, R62. May cause harm to the unborn child. Possible risk of
impaired fertility.
SAFETY PHRASES:
S45. In case of accident or if you feel unwell, contact a doctor or
Poisons Information Centre
immediately (show the label where possible).
SUSDP CLASSIFICATION:
S4 (Aust), S2 (NZ)
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good.
UN NUMBER:
None allocated
E
E
E
M
M
M
E
E
E
R
R
R
G
G
G
E
E
E
N
N
N
C
C
C
Y
Y
Y
O
O
O
V
V
V
E
E
E
R
R
R
V
V
V
I
I
I
E
E
E
W
W
W
PHYSICAL DESCRIPTION & COLOUR
: Aqueous solution.
ODOUR:
No data.
MAJOR HEALTH HAZARDS:
may cause harm to unborn children, possible risk of impaired
fertility.
P
P
P
O
O
O
T
T
T
E
E
E
N
N
N
T
T
T
I
I
I
A
A
A
L
L
L
H
H
H
E
E
E
A
A
A
L
L
L
T
T
T
H
H
H
E
E
E
F
F
F
F
F
F
E
E
E
C
C
C
T
T
T
S
S
S
INHALATION
SHORT TERM EXPOSURE:
Significant inhalation exposure is considered to be unlikely.
Available data indicates that this
product is not harmful. In addition product is unlikely to cause any
discomfort or irritation.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmfu